
Number of publications published per year by Davidson, Brian. (Source : PubMed)

Distribution of publications types for Davidson, Brian. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Limited Penetration of Perfluorocarbon in Porcine Pancreas Preserved by Two-Layer Method with (1) Fluorine Magnetic Resonance Spectroscopy and Headspace Gas Chromatography.
Cell Transplant
2010
Exploring the peritoneal surface malignancy phenotype-a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models.
Hum. Pathol.
2010
Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.
Clin. Exp. Metastasis
2010;27;3
Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma.
Hum. Pathol.
2010
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma.
Int. J. Cancer
2010;126;2
Genomic aberrations in borderline ovarian tumors.
J Transl Med
2010;8
Breast carcinoma cells in primary tumors and effusions have different gene array profiles.
J Oncol
2010;2010


Pathogenesis of ovarian cancer: clues from selected overexpressed genes.
Future oncology (London, England)
2009;5;10

Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters.
Am. J. Clin. Pathol.
2009;132;5

Tenascin-X is a novel diagnostic marker of malignant mesothelioma.
Am. J. Surg. Pathol.
2009;33;11
[ See timeline ] [ See all publications ]
means that Davidson, Brian has 53 papers cited a least 53 times - methodology
Department of Surgical Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.